{"id":"NCT02126839","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","briefTitle":"A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics","officialTitle":"A Three-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler (MDPI) Relative to Placebo in Pediatric Asthmatics","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05","primaryCompletion":"2015-02","completion":"2015-02","firstPosted":"2014-04-30","resultsPosted":"2016-02-05","lastUpdate":"2021-11-09"},"enrollment":186,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Albuterol MDPI","otherNames":["Spiromax®"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"ProAir HFA inhaler","otherNames":["albuterol"]}],"arms":[{"label":"Placebo MDPI QID","type":"PLACEBO_COMPARATOR"},{"label":"Albuterol MDPI 180 mcg QID","type":"EXPERIMENTAL"}],"summary":"The study is to evaluate the chronic-dose efficacy and the safety of Albuterol MDPI compared to placebo in pediatric participants with asthma.","primaryOutcome":{"measure":"Baseline Adjusted Percent Predicted Forced Expiratory Volume In 1 Second (FEV1) Area Under The Concentration Time Curve Up From Time Zero up to 6 Hours (AUC0-6) Over 3 Weeks","timeFrame":"30 ±5 and 5 ±2 minutes prior to dosing, and at 5 ±2, 15 ±5, 30 ±5, 45 ±5, 60 ±10, 120 ±10, 240 ±10, and 360 ±10 minutes after completion of dosing on Days 1 and 22","effectByArm":[{"arm":"Placebo MDPI QID","deltaMin":18.71,"sd":3.19},{"arm":"Albuterol MDPI 180 mcg QID","deltaMin":43.73,"sd":3.2}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":52,"countries":["United States","Thailand"]},"refs":{"pmids":["27523719"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":92},"commonTop":["Headache","Cough","Abdominal pain upper","Vomiting","Pyrexia"]}}